---
title: "Nasus Pharma (NSRX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/NSRX.US/norm.md"
symbol: "NSRX.US"
name: "Nasus Pharma"
parent: "https://longbridge.com/zh-HK/quote/NSRX.US.md"
datetime: "2026-03-14T22:59:10.204Z"
locales:
  - [en](https://longbridge.com/en/quote/NSRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NSRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NSRX.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/NSRX.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/NSRX.US/norm.md)


# Nasus Pharma (NSRX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0850 | -0.0850 | -0.0461 | -0.0461 | -0.0640 |
| ROE | 55.35% | 63.46% | 41.53% | 33.88% | 37.96% |
| Revenue | - | - | - | - | - |
| Net income | -626000.00 | -626000.00 | -330500.00 | -330500.00 | -435500.00 |
| Operating income | -408500.00 | -408500.00 | -297500.00 | -297500.00 | -241500.00 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 639000.00 | 639000.00 | 717000.00 | 717000.00 | 1.02M |
| Leverage | -0.1481 | -0.1481 | -0.2232 | -0.2232 | -0.2187 |
| BVPS | -0.5859 | -0.5859 | -0.4362 | -0.4362 | -0.6768 |
| Turnover | - | - | - | - | - |
| Cash & STI | 203000.00 | 203000.00 | 284000.00 | 284000.00 | 900000.00 |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | 2.36M | 2.36M | 1.52M | 1.52M | 2.90M |

## 現金流量表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -216500.00 | -216500.00 | -242500.00 | -242500.00 | -90000.00 |
| Investing CF | - | - | - | - | - |
| Financing CF | 180000.00 | 180000.00 | -55500.00 | -55500.00 | 440500.00 |
| Free CF | -180313.00 | 167687.00 | -183438.00 | -79438.00 | -148438.00 |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |